Chairman Of The Board @ VERALOX Therapeutics (September 2020 - January 2026)
Director @ (July 2019 - October 2025)
Chief Executive Officer @ Palladio Biosciences, Inc. (August 2019 - September 2022)
Board Director @ (September 2016 - July 2019)
CEO @ (June 2015 - July 2019)
President @ (June 2011 - May 2015)
CEO @ Affectis Pharmaceuticals (June 2009 - January 2011)
COO @ (April 2007 - May 2009)
CFO and CBO @ (January 2003 - January 2007)
VP Business Development @ (January 2001 - January 2003)
EVP Pharmaceutical Sales and Marketing @ (January 1997 - January 2001)
Sales, Marketing, and Business Development @ (January 1989 - January 1997)
Alex Martin Education
Harvard Business School
MBA (General Management)
1993-1995
Cornell University
BA (Political Science and Government)
1985-1989
Scarsdale High School
Alex Martin Skills
Biotechnology
Business Development
Business Strategy
Clinical Development
Commercialization
Corporate Development
Cross-functional Team Leadership
Drug Development
Due Diligence
Financial Modeling
Licensing
Lifesciences
Mergers
Pharmaceutical Industry
Start-ups
Strategic Alliances
Strategic Partnerships
Strategic Planning
Strategy
Venture Capital
Cross Functional Team Leadership
Start Ups
Sales
Social Media
Microsoft Office
Financial Analysis
JavaScript
Alex Martin Summary
Alex Martin, based in Princeton, NJ, US, is currently a Chief Executive Officer at Abcuro, Inc. Alex Martin brings experience from previous roles at VERALOX Therapeutics, ESSA Pharmaceuticals, Palladio Biosciences, Inc. and RASNA THERAPEUTICS LIMITED. Alex Martin holds a 1993 - 1995 MBA in General Management @ Harvard Business School. With a robust skill set that includes Biotechnology, Business Development, Business Strategy, Clinical Development, Commercialization and more. Alex Martin has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Alex Martin?
Find contact details for 700 million professionals.